BusinessCann
BusinessCann · page 4
- Uncategorized
Iuvo erforscht neue Cannabisquellen in Israel als Vorbereitung auf die Legalisierung in Deutschland
IUVO Therapeutics GmbH (“iuvo”) und Advanced Canna Technologies Ltd. (“ACT”) haben eine unverbindliche Absichtserklärung (LOI) über die Lieferung von Cannabisblüten unterzeichnet.
- Press releases
Kanvas Receives Strategic Investment from Btomorrow Ventures, A Division Of BAT, As Lead Investor
THE Kanvas Co. (“Kanvas”), developer of patented electronic vaporizer technology solutions designed to deliver device safety, performance, and reliability for nicotine, cannabis, and cannabidiol (CBD) delivery systems, today announced the completion of a strategic investment (the ”Investment”).
- Press releases
4C LABS Awarded MS Licence & WDA Licence To Operate A Distribution Facility In The UK
4C LABS Ltd., a London based Phyto Pharma company focused on the medical cannabis space, has been granted Importation and Distribution licences by the UK Medicines and HealthCare Products Regulatory Authority (MHRA).
- Press releases
Firms Back Call Of Billy Caldwell’s Mother To Gift Medical Cannabis To Epileptic Children
Three manufacturers answer call from the I AM Billy Foundation, led by campaigner Charlotte Caldwell, to supply free medicine – with more to follow As many as 75 families of severely epileptic children could benefit from free private medicines – saving each patient up to £6,000 while waiting for NHS funding Charlotte says: “No parent…
- Press releases
Tilray Medical Bolsters Market Leading Position In Europe With Market Authorisation In Poland
TILRAY Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced that its medical cannabis division, Tilray Medical, has received approval to commercialize its Tilray branded medical cannabis products in Poland expanding…
- Press releases
Cellular Goods Announces Appointment Of New Chief Financial Officer
CELLULAR Goods (LSE: CBX), a UK-based wellness company providing premium consumer products formulated with lab-produced cannabinoids, is pleased to announce the appointment of Bruna Nikolla as Chief Financial Officer.
- Press releases
British People Open To Using Medical Cannabis – Yet Majority Unaware They Can Access It On Prescription
A NEW national survey of 4,000 people has highlighted the need to improve awareness of cannabis as a medicine.
- Press releases
Chrystal Capital Acts As Exclusive Advisor To Change Agronomy On £9.6m Fundraise
CHRYSTAL Capital Partners LLP, is an entrepreneurial corporate finance and investment house with an established global network of Single Family Offices (SFOs), Ultra High Net Worth Individuals (UHNWIs) and private equity co-investment partners.
- Press releases
Akanda To Supply Cansativa With Premium Indoor Cannabis Flower Grown At Its Sintra Facility In Portugal
INTERNATIONAL medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced it has signed a multi-year supply agreement with European medical cannabis leader Cansativa GmbH (“Cansativa Group” or “Cansativa”) to supply EU-GMP quality THC dried flower strains cultivated from its Portuguese operations at Holigen.
- News
The Tel Aviv Stock Exchange Scraps TA-Cannabis Index After Less Than 2 Years
As reported in The Israeli Cannabis Magazine THE Tel Aviv Stock Exchange, the body entrusted with compiling the stock indices, announced last week that as of August 4 the TA Cannabis Index, made up of Israel’s largest cannabis stocks, will cease to exist.
- Press releases
Cannasouth Research Shows Cannabinoids Could Provide Relief For Thousands Of New Zealanders From Debilitating Neuropathic Pain
A THREE-YEAR neuropathic pain (pre-clinical) study by Cannasouth has confirmed that cannabinoids from medicinal cannabis could be effective at reducing debilitating neuropathic pain, which affects about 400,000 New Zealanders or 8 per cent of the country’s population.
